A detailed history of Redmont Wealth Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Redmont Wealth Advisors LLC holds 201 shares of ABBV stock, worth $33,617. This represents 0.05% of its overall portfolio holdings.

Number of Shares
201
Holding current value
$33,617
% of portfolio
0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $32,123 - $36,602
201 New
201 $36,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $13,831 - $16,587
100 Added 2.77%
3,707 $599,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $163,736 - $187,794
-1,220 Reduced 25.27%
3,607 $484,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $1,651 - $2,099
-12 Reduced 0.25%
4,827 $739,000
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $82,091 - $101,852
622 Added 14.75%
4,839 $785,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $453,032 - $573,216
4,217 New
4,217 $571,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Redmont Wealth Advisors LLC Portfolio

Follow Redmont Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmont Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmont Wealth Advisors LLC with notifications on news.